Skip to main content
. Author manuscript; available in PMC: 2017 Apr 18.
Published in final edited form as: Plasma Med. 2016;6(2):135–177. doi: 10.1615/PlasmaMed.2016018618

Table 1.

A summary of the various laboratories and institutes involved in plasma medicine research, predominantly the application of plasma plume technologies for topical (e.g., dermal) applications, and/or to perform in vitro cell assay experiments

University / Institute Application Ref.
Ajou University Cancer (in vitro) 2430
Changchun University of Science and Technology Cancer (in vitro) 31
Clemson University Melanoma (in vitro) 32
Conway Institute of Biomolecular and Biomedical Research Cancer (in vitro) 33
CSIRO Cancer (in vitro) 34,35
Drexel University Dermal applications; disinfection; melanoma (in vivo); cancer (in vitro) 3648
Dong-A University Cancer (in vitro) 4952
Eindhoven University of Technology Disinfection, cancer (in vitro) %53
George Washington University Fibroblast modification; wound healing; cancer (in vitro); electrosurgery %54–%67
Heinrich-Heine University Skin infection, wound healing %68
Kanazawa University Wound healing %69
Korea Advanced Institute of Science and Technology Cancer (in vitro) %70
Kwangwoon University Plasma Bioscience Research Center Cancer (in vitro) %71–%73
Leibniz Institute for Plasma Science and Technology Dermal applications; cancer (in vitro) %74–%88
Max Planck Institute Dermal applications; cancer (in vitro) %89–%91
McGill University Cancer (in vitro) %92,%93
Nagoya University Cancer (in vitro); anti-fungal; macular degeneration %94–%104
National Institute for Laser, Plasma, and Radiation Physics Cancer (in vitro) %105
Old Dominion University Fungal decontamination, cancer (in vitro) %106,%107
Plasma Engineering Research Lab, Texas A&M Surface decontamination, antibiotic-resistant bacteria, wound treatment, cancer (in vitro) %108–%117
Pohang University Melanoma %118,%119
Pusan National University Melanoma %120
Queen's University Belfast Centre for Plasma Physics Nosocomial infection prevention, biofilm eradication, cancer (in vitro) %121–%128
Shahid Beheshti University Melanoma %129
Umversite' d'Orleans Subcutaneous tumor treatement (murine model) %130–%134
University of Buffalo Melanoma %135,%136
University of Campinas Fibroblast modification %137
University of Iasi Dermal applications %138
University of Notre Dame Cancer (in vitro) %139
York Plasma Institute, University of York Cancer (in vitro) %140
HHS Vulnerability Disclosure